Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC

Recruiting now

Conditions studied: Hepatocellular Carcinoma (HCC)

In brief

Tumor-draining lymph nodes play an important role in anti-tumor immune responses. In patients with hepatocellular carcinoma (HCC), however, the relationship between regional lymph node metastasis (LNM) and immunotherapy-based efficacy is unclear. This study aimed to evaluate whether extrahepatic LNM is associated with worse survival outcomes as compared to other metastatic sites in patients with advanced HCC.

Key facts

Study ID
NCT06876753
Run by
Zhongda Hospital
People needed
300
Starts
2018-06-01
Expected to finish
2025-07-01
Last updated by the study team
2025-03-14

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.